Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
•To evaluate the efficacy of lebrikizumab compared with placebo in improving lung function, as measured by the absolute change in pre-bronchodilator forced expiratory volume in 1 second (FEV1), in adult patients with mild-to-moderate asthma treated with SABA only. •To evaluate the safety of lebrikizumab compared with placebo in patients with mild-to-moderate asthma treated with SABA only, focusing on the nature, frequency, and severity of serious and non-serious adverse events.
Critère d'inclusion
- Asthma